Glezer Stanislav 4

4 · Inogen Inc · Filed Mar 5, 2024

Form 4

Period: 2024-03-01

EVP, Chief Medical Officer

Transactions

Exercise/Conversion
Common Stock
2024-03-01+13,914→ 23,729 total
Tax Payment
Common Stock
2024-03-01$7.03/sh−7,623$53,552→ 16,106 total
Exercise/Conversion
Restricted Stock Unit
2024-03-01−768→ 4,612 total
→ Common Stock (768 underlying)
Exercise/Conversion
Restricted Stock Unit
2024-03-01−3,786→ 3,787 total
→ Common Stock (3,786 underlying)
Exercise/Conversion
Restricted Stock Unit
2024-03-01−9,360→ 18,719 total
→ Common Stock (9,360 underlying)
Award
Restricted Stock Unit
2024-03-01+43,993→ 43,993 total
→ Common Stock (43,993 underlying)

Footnotes (6)

[F1]The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2024.
[F2]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
[F3]Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.
[F4]Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.
[F5]Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.
[F6]Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2025, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Documents

1 file